Fake COVID vax proofs sold to healthcare workers

Amy Baxter | | Health Exec | COVID-19
vaccine syringe covid-19 coronavirus

Fake COVID-19 vaccine cards were sold for $200 apiece to individuals in the New York City area, including some healthcare professionals.

The fake cards were sold by a New Jersey woman under the name AntiVaxMomma on Instagram, NPR reported. Jasmine Clifford was charged with offering a false instrument, criminal possession of a forged instrument and conspiracy for allegedly selling roughly 250 fake vaccine cards.

At a higher cost of $250, a second individual, Nadayza Barkley, entered the name of the fake card buyer into a New York state vaccination database that verifies vaccination status at required settings. According to prosecutors, Barkley entered at least 10 names into the vaccine database, NPR reported. Another 13 card buyers were also charged. 

Fake vaccine cards are a rising concern, particularly amid reports of healthcare workers taking part. 

See the full story below:

 

Fake Vaccination Cards Were Sold To Health Care Workers On Instagram

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

DEA wants to permanently anchor some COVID-era prescription regulations
Monitoring acute heart patients at home linked to considerable cost savings
Brazen marital healthcare scheme ends with guilty pleas
CityMD agrees to $12M settlement over alleged COVID claims fraud
Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes
Does Covid-19 raise risk for cancers—including rare ones?

Around the web

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.